SC Filed 2024-01-09 Event — SEC 0000919574-24-000217 →

Casdin Capital, LLC → STANDARD BIOTOOLS INC. LAB

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100 · Filer 90d Win Rate: 33% · Hist. 90d Edge: +5.5%

Filer track record (5 filings): 33% 90d win rate, +5.5% 90d edge
Held by 2 tracked 13F institutional managers

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

13 transactions

6 buys · 0 sales · 4 awards/exercises

Issuer Cluster

11 13D/G filings on this issuer

10 other filings besides this one

Filer Track Record

12 filings by this filer

11 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 2.50

2,445,793 shares short · -3.0% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers

2 holders · $48.44M

Point72 Asset MgmtViking Global

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-23	Kim Hanjoon Alex	officer	F	202,476	$0.90	$181K
2026-04-06	Kim Hanjoon Alex	officer	Option exercise	70,183	—	—
2026-04-06	Kim Hanjoon Alex	officer	F	21,301	$0.91	$19K
2026-04-06	Kim Hanjoon Alex	officer	Option exercise	70,183	—	—
2026-04-06	Egholm Michael	director, officer	Option exercise	196,513	—	—
2026-04-06	Egholm Michael	director, officer	F	95,014	$0.91	$86K
2026-04-06	Egholm Michael	director, officer	Option exercise	196,513	—	—
2026-03-20	Egholm Michael	director, officer	Award	1,042,373	—	—
2026-03-20	Mackay Sean	officer	Award	272,107	—	—
2026-03-20	Kim Hanjoon Alex	officer	Award	323,173	—	—
2026-03-20	Kim Hanjoon Alex	officer	Award	727,140	$0.98	$716K
2026-03-20	Mackay Sean	officer	Award	612,240	$0.98	$603K
2026-03-20	Egholm Michael	director, officer	Award	2,345,340	$0.98	$2.31M

Other 13D/G Filings on STANDARD BIOTOOLS INC.

Filed	Form	Filer	Stake	Shares
2026-06-12	SCHEDULE 13D	VIKING GLOBAL INVESTORS LP	15.00%	58,651,170	view →
2026-06-09	SCHEDULE 13D/A	Casdin Capital, LLC	23.90%	88,783,856	view →
2025-03-04	SCHEDULE	Casdin Capital, LLC	21.60%	80,864,315	view →
2024-01-08	SC	Caligan Partners LP	—	—	view →
2023-07-03	SC	Caligan Partners LP	—	—	view →
2022-08-05	SC	Caligan Partners LP	—	—	view →
2019-04-02	SC	LEVIN CAPITAL STRATEGIES, L.P.	—	—	view →
2019-03-20	SC	LEVIN CAPITAL STRATEGIES, L.P.	—	—	view →
2018-03-06	SC	LEVIN CAPITAL STRATEGIES, L.P.	—	—	view →
2018-01-11	SC	LEVIN CAPITAL STRATEGIES, L.P.	—	—	view →

Other Filings by Casdin Capital, LLC

Filed	Form	Issuer	Stake	Shares
2026-06-09	SCHEDULE 13D/A	Standard BioTools Inc. LAB	23.90%	88,783,856	view →
2026-06-04	SCHEDULE 13G	BIOLIFE SOLUTIONS INC BLFS	—	—	view →
2026-05-22	SCHEDULE 13D/A	BIOLIFE SOLUTIONS INC BLFS	9.70%	4,757,165	view →
2025-08-13	SCHEDULE	BIOLIFE SOLUTIONS INC BLFS	15.00%	7,207,165	view →
2025-03-07	SCHEDULE	Tenaya Therapeutics, Inc. TNYA	4.30%	6,732,971	view →
2025-03-04	SCHEDULE	STANDARD BIOTOOLS INC. LAB	21.60%	80,864,315	view →
2023-03-20	SC	Absci Corp ABSI	—	—	view →
2022-11-28	SC	Tenaya Therapeutics, Inc. TNYA	—	—	view →
2022-10-11	SC	Century Therapeutics, Inc. IPSC	—	—	view →
2020-05-18	SC	GenMark Diagnostics, Inc.	—	—	view →
2020-02-07	SC	GenMark Diagnostics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →